Richard F. Hank
Pfizer (United States)(US)
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Pancreatic function and diabetes, Receptor Mechanisms and Signaling, Diabetes Treatment and Management, Neuropeptides and Animal Physiology
Most-Cited Works
- → Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands: potent, TRβ subtype-selective thyromimetics(2003)94 cited
- → An Optimized Process for Formation of 2,4-Disubstituted Imidazoles from Condensation of Amidines and α-Haloketones(2002)46 cited
- → The design and synthesis of indazole and pyrazolopyridine based glucokinase activators for the treatment of Type 2 diabetes mellitus(2012)44 cited
- → Structure–activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists(2003)26 cited
- → Identification of spirocyclic piperidine-azetidine inverse agonists of the ghrelin receptor(2012)26 cited
- → Glucose Transport-Enhancing and Hypoglycemic Activity of 2-Methyl-2-phenoxy-3-phenylpropanoic Acids(1996)23 cited
- → Pyrimidone-based series of glucokinase activators with alternative donor–acceptor motif(2013)22 cited
- → From partial to full agonism: Identification of a novel 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole as a full agonist of the human GPR119 receptor(2012)21 cited
- → Structure–activity relationships in a series of NPY Y5 antagonists: 3-amido-9-ethylcarbazoles, core-modified analogues and amide isosteres(2003)15 cited
- → A convenient synthesis of 1‐aryl‐3‐methyl‐1,2,4‐triazolin‐5‐ones from the reaction between acetone arylhydrazones and acetyl isocyanate(1990)4 cited